No profile data available.
Standard BioTools Inc. (LAB) is a healthcare company in the biological analysis equipment industry, based in Boston, United States, with about 385 full-time employees.
It reported revenue of $174.43 million for fiscal year 2024, up 64.0% from fiscal year 2023, and net income of -$184.90 million. In Q3 2025 (the quarter ended September 30, 2025) revenue was $19.55 million, down 56.5% from a year before. United States was its largest region in fiscal year 2025, with 33% of revenue. Its market capitalization was $270.64 million as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2024; market data as of October 9, 2026.
, together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop therapeutics in the Americas, Europe, the Middle East, Africa, and the Asia pacific. The company operates through Proteomics and Genomics segments.
Standard BioTools reported $174.43 million in revenue for fiscal year 2024, up 64.0% from $106.34 million in fiscal year 2023. In Q3 2025 revenue was $19.55 million.
United States: 33% of revenue by region in fiscal year 2025, followed by Emea Excl. Sweden (32%).
$270.64 million as of October 9, 2026.
Listed companies of a similar size in the same industry (biological analysis equipment) include Alpha Teknova, Inc. (TKNO), Quantum-Si incorporated (QSI), Nautilus Biotechnology, Inc. (NAUT), Quanterix Corporation (QTRX).